I see Jason Kolbert's name on that list. I listened to the Athersys conference call a week or so ago just to see where they are at. CEO had a few snips at MSB (without mentioning it by name) for touting the compassionate use results as though that was somehow inappropriate. Of course he didn't mention the phase 3 trial which was by then up and running. Interestingly, @LeftYahoo has a theory (I think) that Athersys lacked the confidence in its own therapy to run its own compassionate use trial for COVID/ARDS. Anyway, Kolbert put up a series of highly obsequious questions which were very flattering of CEO. It was truly pathetic, and left me wondering what it was all about. Perhaps he was favourably involved in Athersys' last cap raise. Will be interested to see how enthisiastic he is for MSB during the call. He may be backing a different horse. Cheers.
MSB Trading - 2020, page-10521
-
- There are more pages in this discussion • 12,640 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |